ClinicalTrials.Veeva

Find clinical trials for Multiple Sclerosis (MS) in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Sclerosis
Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Chronic Progressive Multiple Sclerosis
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Muscle Spasticity

Multiple Sclerosis (MS) trials near Salt Lake City, UT, USA:

Locations recently updated

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis (NEOS)

Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...

Enrolling
Multiple Sclerosis (MS)
Drug: Siponimod
Drug: Ofatumumab

Phase 3

Novartis
Novartis

Salt Lake City, Utah, United States and 73 other locations

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...

Enrolling
Multiple Sclerosis
Drug: Placebo capsule
Drug: Fingolimod

Phase 3

Novartis
Novartis

Salt Lake City, Utah, United States and 107 other locations

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

Enrolling
Relapsing Multiple Sclerosis
Drug: Teriflunomide
Drug: Remibrutinib

Phase 3

Novartis
Novartis

Salt Lake City, Utah, United States and 208 other locations

This is a Phase 1 study of IMS001, given as a single dose to subjects with Multiple Sclerosis who experience inadequate response an...

Enrolling
Multiple Sclerosis
Biological: IMS001

Phase 1

ImStem Biotechnology

Salt Lake City, Utah, United States and 2 other locations

The ALSpire Study is a clinical trial evaluating the investigational drug BIIB105 in adults living with amyotrophic lateral sclerosis (ALS)....

Active, not recruiting
Amyotrophic Lateral Sclerosis
Drug: Placebo
Drug: BIIB105

Phase 1, Phase 2

Biogen
Biogen

Salt Lake City, Utah, United States and 16 other locations

The primary purpose of this phase 3b study is to assess efficacy after transition from a current DMT to ublituximab, as measured by T1 Gadolinium (Gd...

Enrolling
Relapsing Multiple Sclerosis
Biological: Ublituximab

Phase 3

TG Therapeutics
TG Therapeutics

Salt Lake City, Utah, United States and 20 other locations

Locations recently updated

) neo-antigen in subjects with relapsing multiple sclerosis (RMS)....

Enrolling
Relapsing Multiple Sclerosis
Biological: 13-valent pneumococcal conjugate vaccine (13-PCV)
Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Phase 3

Novartis
Novartis

Salt Lake City, Utah, United States and 301 other locations

Status recently updated

The objective of this study is to assess the long-term safety, tolerability, and efficacy of adjunctive therapy of LP352 in subjects with development...

Enrolling
Active, not recruiting
Developmental and Epileptic Encephalopathy
Lennox-Gastaut Syndrome
Drug: LP352, bexicaserin

Phase 2

Longboard Pharmaceuticals

Salt Lake City, Utah, United States and 27 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems